characteristics.text: SAMN41526142
characteristics.characteristic: External Id
characteristics.text: Rinath Jeselsohn Lab, Medical Oncology, Dana-Farber Cancer Institute
characteristics.characteristic: INSDC center name
characteristics.text: 2024-06-01T00:52:26.420Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-06-01T00:52:26.420Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS21418815
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS21418815
characteristics.characteristic: SRA accession
characteristics.text: PDX1526
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: Y537S mutant ER
characteristics.characteristic: genotype
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: PDX1526 model
characteristics.characteristic: source_name
characteristics.text: 28 days
characteristics.characteristic: time
characteristics.text: PDX1526 model
characteristics.characteristic: tissue
characteristics.text: PDX1526; Y537S mutant ER; Fulvestrant (5mg/mouse/wk subcutaneous); 28 d; biol rep 1
characteristics.characteristic: title
characteristics.text: Fulvestrant (5mg/mouse/week subcutaneous)
characteristics.characteristic: treatment